Abstract
Currently, the genetic diagnosis of individuals at risk for hereditary cancer predisposition syndromes (HCPS) is carried out through the sequencing of a new generation of multigenic panels containing from ten to a hundred cancer predisposition genes (GPC). Recent studies in the literature and in our group show that a small portion of patients with SPHC has pathogenic / probably pathogenic…